Abstract. Diagnosis and control of Foot-and-mouth disease virus (FMDV) requires rapid and sensitive diagnostic tests. Two antibody enzyme-linked immunosorbent assay (ELISA) kits, Ceditest® FMDV-NS for the detection of antibodies against the nonstructural proteins of all FMDV serotypes and Ceditest® FMDV type O for the detection of antibodies against serotype O, were evaluated under African endemic conditions where the presence of multiple serotypes and the use of nonpurified vaccines complicate serological diagnosis. Serum samples from 218 African buffalo, 758 cattle, 304 goats, and 88 sheep were tested using both kits, and selected samples were tested not only in serotype-specific ELISAs for antibodies against primarily FMDV serotype O, but also against other serotypes. The FMDV-NS assay detected far more positive samples (93%) than the FMDV type O assay (30%) in buffalo (P < 0.05), with predominant antibodies against the South African Territories (SAT) serotypes, while the seroprevalence was generally comparable in cattle with antibodies against serotype O elicited by infection and/or vaccination. However, some districts had higher seroprevalence using the FMDV type O assay indicating vaccination without infection, while 1 cattle herd with antibodies against the SAT serotypes had far more positive samples (85%) using the FMDV-NS versus the FMDV type O (10%), consistent with the latter test's lower sensitivity for antibodies against SAT serotypes. Based on the current investigation, the FMDV type O ELISA may be limited by the presence of SAT serotypes. The FMD NS assay worked well as a screening test for antibodies against all FMDV serotypes present in Uganda; however, as long as nonpurified vaccines are applied in the region, this test cannot be used to differentiate between vaccinated and infected animals.
Introduction
Foot-and-mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals including domestic ruminants, pigs, and more than 70 wild animal species. 1, 21 Footand-mouth disease virus (FMDV; order Picornavirales, family Picornaviridae, genus Aphthovirus) contains 7 serotypes, namely O, A, C, Asia1, Southern African Territories (SAT)1, SAT2, and SAT3, all with a number of subtypes. Infection with 1 serotype does not prevent infection with other serotypes. 8 Different serotypes have distinct geographical distributions and epidemiology; however, they are clinically indistinguishable. 22 The epidemiology of FMD in East Africa is complex with 5 (O, A, SAT1, SAT2, and SAT3) out of the 7 serotypes being continuously present. 22 Serotype C was last diagnosed in Kenya in 2004 18 while serotype Asia1 has never been diagnosed on the African continent. 22 Previously, serological diagnosis of FMDV implied running up to 7 different tests for antibodies against each of the relevant serotypes; however, more broadly directed antibody tests detecting antibodies against all 7 serotypes of FMDV have recently been offered by a number of commercial companies, including an enzyme-linked immunosorbent assay (ELISA) kit for detection of antibodies against all 7 serotypes of FMDV marketed by Prionics AG, Switzerland: the Ceditest® FMDV-NS a (hereafter, NSP test). The same company has marketed a screening test for detection of antibodies against serotype O, the Ceditest® FMDV type O ELISA kit b (hereafter, SP-O test), which has such broad specificities for antibodies against the Eurasian serotypes of FMDV (O, A, C, and Asia1) 9 that it has been speculated that this test could work as a pan-FMDV antibody test.
The NSP test is a blocking ELISA that detects antibodies against the nonstructural 3ABC protein of FMDV in infected animals, independent of the serotype that induced the antibodies. 19 Like other commercially available test kits for antibodies against the nonstructural proteins (NSPs) of FMDV, the NSP assay has important applications in differentiating infected from vaccinated animals. 19 Conversely, the SP-O assay is based on the structural proteins (SPs) of FMDV serotype O and can be used in cattle, sheep, pigs, and goats. 9 These 2 test kits have been successfully used for investigating FMD outbreaks and for control programs. 9, 16, 17 The NSP ELISAs are widely applied in the diagnosis of FMD and have been evaluated in Europe 5 and to a lesser extent in Africa. 6, 7 In a direct comparison of 6 NSP ELISAs, the NSP test had comparative sensitivities of 98.9% and 96.6% in field sera from Israel and Zimbabwe, respectively, while diagnostic specificity was 97.2% in nonvaccinated animals and 99.5% in experimental animals that had received 1 vaccination. 5 In Africa, using Hui-Walter latent class modeling and comparing with a combination of neutralization test results for all 3 SAT serotypes of FMDV, it has been demonstrated that the NSP test is a useful tool for screening buffalo infected with multiple SAT serotypes of FMDV with estimated sensitivity of 87.7% and specificity of 87.3%. 6 Using the same modeling methodology but without comparing to neutralization test results, estimated sensitivity and specificity of 96.6% and 90.9%, respectively, have been found in Zebu cattle kept under extensive rangeland conditions in Cameroon. 7 Although only limited studies of performance of these tests have been carried out among sheep and goats, lower sensitivity has been reported particularly in sheep. 13 The SP-O test has mainly been used and evaluated in Europe and has been found to identify antibodies against serotypes O, A, C, and Asia1 in cattle, with higher sensitivity for antibodies against serotype O. 9 The aim of the present study was to evaluate the performance of the SP-O and NSP tests in Ugandan cattle, sheep, goats, and African buffalo (Syncerus caffer). In addition, the SP-O test was compared to a solid phase blocking ELISA (SPBE) for detection of antibodies against FMDV serotype O. 4 
Materials and methods
Serum samples were collected from Ugandan African buffalo, cattle, goats, and sheep. Two hundred eighteen samples from African buffalo were collected from Lake Mburo, Kidepo Valley, Murchison Falls, and Queen Elizabeth National Parks as described elsewhere. 2, 3 In addition, 449 cattle sera were collected in July 2006 during an extensive postoutbreak (PO) sampling in a number of districts in the western and southwestern regions of Uganda and 309 sera were collected during an attempted random sampling (RS) within Kasese and Bushenyi Districts in 2007.
14, 15 Three hundred four goat sera and 88 sheep sera were collected from the same farms or villages during these sampling trips. 4 Testing for antibodies against FMDV was done using the NSP a and SP-O b tests according to the manufacturer's instructions. Optical density values (OD) were determined using a dual wavelength ELISA reader c at 620 nm and 450 nm. Results were expressed as OD% (ODP: ODsample in percent of ODnegative controls), 4 and cutoffs were set at 50%. Selected samples, mostly positive for antibodies against NSPs, were screened at dilution 1:5 using an in-house SPBE for antibodies against FMDV serotype O (SPBE-O) with a cutoff of 50% as previously described. 4 The 15 were examined in SPBEs for antibodies against all 7 serotypes of FMDV as previously described. 4 Differences between groups were tested for statistical significance using chi-square, and differences between seroprevalence obtained with the NSP and SP-O tests were analyzed using McNemar test in a spreadsheet program. 
Results
Antibodies against NSPs, and SPs of FMDV serotype O, were detected in African buffalo, cattle, goat, and sheep samples ( Table 1) . Seroprevalence of antibodies against NSP was much higher in African buffalo (93%) compared to cattle (48%), sheep (28%), and goats (9%), while cattle had the highest number of positives in the SP-O test (52%) compared to buffalo (30%) sheep (24%), and goats (7%).
In buffalo, for both tests, there was no significant difference in the seroprevalence of FMDV antibodies between national parks (P = 0.758 and P = 0.413 for the NSP and SP-O tests, respectively). Thus, the data from all buffalo samples were pooled, and statistical analysis of these results confirmed that the NSP test detected significantly more seropositive buffalo than the SP-O test (P < 0.005) in all the 4 investigated national parks.
The (Table 2 ).
In the 2006 PO sampling, on-farm seroprevalence in the NSP and SP-O tests were generally comparable 14 ; however, 1 out of 22 cattle herds (Ks12) with a history of recent clinical signs of FMD had much higher prevalence of antibodies against FMDV in the NSP test than in the SP-O test. 14 Analysis of serotype-specificity of FMDV antibodies of 20 heads of cattle from this herd using SPBEs for all 7 serotypes revealed that these cattle exclusively had antibodies against the SAT serotypes ( Table 3) . Most of these 20 samples had low antibody titers against serotypes SAT2 and SAT3; however, 1 animal had a titer of 80 for antibodies against SAT2, 3 animals had titers of 80-160 against SAT3, and 1 animal had a titer of 640 against SAT1. This herd was regularly grazed in Queen Elizabeth National Park.
Discussion
Interpretation of the higher seroprevalence of antibodies against NSPs than against SPs of FMDV serotype O in the investigated buffalo sera should take into consideration that when titrated, these sera had higher seroprevalences of antibodies against the FMDV SAT serotypes than against serotype O. 2, 3 Thus, these data suggest that the SP-O test may be much less sensitive for antibodies against the SAT serotypes of FMDV circulating in Uganda than the NSP test. It may be speculated that the low sensitivity of the SP-O test in buffalo could be species-related; however, this test is a blocking ELISA, which is generally not species-specific. Moreover, the similar finding in a cattle herd (Ks12) of much higher seroprevalence in the NSP test and in the SPBEs for antibodies against the SAT serotypes than in both the SP-O and SPBE-O tests supports that the low sensitivity in buffalo was not species-related.
In cattle, the high seroprevalence in both tests in most districts in 2006 were found during a major outbreak of FMDV serotype O in the region in 2006, which was preceded and followed by vaccination campaigns with nonpurified trivalent vaccines containing FMDV serotypes O, SAT1, and SAT2. Moreover, the majority of the sampled herds exhibited clinical evidence of exposure to FMDV and/or reported previous vaccination, and a serotype O virus was isolated from 2 probang samples collected from this outbreak. 15 In agreement with this, all herds with clinical evidence of FMDV infection, except the 1 Kasese herd described in Table 3 (Ks12), had high seroprevalence in the SP-O test and had high titers of antibodies against serotype O in the SPBE-O ELISA. 15 The higher seroprevalence registered with the SP-O test in Mbarara, Kiruhura, and Kampala districts is consistent with vaccinated animals that have not recently been infected.
The Kasese herd (Ks12; Table 3 ) with much higher seroprevalence in the NSP test (85%) than in the SP-O test (10%) had serological evidence of exposure to SAT serotypes, while all tested samples were negative in the SPBE-O ELISA. Thus, this result supports the preceding conclusion (Table 1) , and half of these samples came from a herd with higher titers of antibodies against the SAT serotypes than against serotype O (K1), 14 confirming the results from Ks12 sampled in 2006, while the remaining 18 samples were dispersed among 10 of the 16 sampled herds. 14 The NSP test, like other commercially available test kits for antibodies against the NSPs of FMDV, have important applications in differentiating infected from vaccinated animals, 19 but this usage may be complicated by nonpurified FMDV vaccines inducing antibodies against the NSPs. The differences between the performances of the NSP test and the SP-O test in small ruminants followed the results in cattle, but were not statistically significant due to low numbers of positives. These variations were most likely results of the presence of antibodies against FMDV serotype O after the outbreak of FMDV serotype O during 2006. 4 The much higher seroprevalence in sheep and goats in the 2006 PO sampling than in the 2007 RS, combined with the higher seroprevalence in cattle in 2007, may indicate faster waning of antibodies in these species than in cattle as previously reported, 11, 12 but could also be a consequence of the common practice of not vaccinating small ruminants. Like other commercially available test kits for antibodies against the NSPs of FMDV, the NSP test has important applications in differentiating infected from vaccinated animals, 21 but this usage may be complicated by detection of antibodies against FMDV NSPs elicited by nonpurified FMDV vaccines, 10, 21 which are applied in some sub-Saharan African countries including Uganda. This was also the case in the samplings in the current study, where nonpurified trivalent vaccines had been used in the area in vaccination campaigns in cattle in 2005, 2006, and 2007 . Thus, in the presented analysis of cattle samples from 2006 and 2007, it is impossible to conclude whether the identified antibodies were induced by vaccination and/or infection. However, the NSP test can still be applied for mass screening to identify animals with antibodies against FMDV whether these are vaccine-derived or elicited by infection. 20 In conclusion, though the SP-O test is of low specificity toward antibodies against the Eurasian FMDV serotypes 9 and it has been speculated that this test could be used as a pan-FMDV antibody test, this usage cannot be recommended in populations where the SAT serotypes of FMDV are prevalent, as exemplified by the SAT-infected buffalo and the cattle herd exposed to 1 or more of the SAT serotypes, only. The SP-O test can be used in combination with the NSP test when investigating FMD outbreaks caused by serotype O; however, it will not be possible to use the NSP test to differentiate between vaccinated and infected animals as long as nonpurified vaccines are applied in the region.
